Gilead Sciences Stock Forecast

Stock Price Forecast

According to 31 analysts polled by S&P Global, Gilead Sciences stock has a consensus rating of "Buy" and an average price target of $157.83. The average 1-year stock price forecast is 25.52% higher than the current stock price, while the lowest is $122 (-2.97%) and the highest is $180 (+43.15%).

Price Target: $157.83 (+25.52%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$122	$157.83	$160	$180
Change	-2.97%	+25.52%	+27.25%	+43.15%

Analyst Ratings

The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	17	17	18	18	18	18
Buy	5	5	5	5	6	6
Hold	6	7	8	8	7	7
Sell	1	1	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	29	30	31	31	31	31

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Terence Flynn Morgan Stanley	Morgan Stanley	Buy Maintains $168	Buy	Maintains	$168	+33.61%	Jun 5, 2026
Gregory Renza Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 3, 2026
Louise Chen Scotiabank	Scotiabank	Buy Maintains $177	Buy	Maintains	$177	+40.77%	Jun 3, 2026
Geoff Meacham Citi	Citi	Buy Maintains $165	Buy	Maintains	$165	+31.22%	Jun 3, 2026
Tazeen Ahmad Bank of America Securities	Bank of America Securities	Buy Maintains $162	Buy	Maintains	$162	+28.84%	Jun 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

30.46B

from 29.44B

3.44%

from 29.44B

Revenue Next Year

32.35B

from 30.46B

6.22%

from 30.46B

EPS This Year

-0.79

from 8.15

EPS Next Year

9.59

from -0.79

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	27.31B	27.28B	27.12B	28.75B	29.44B	30.46B
Revenue Growth	10.60%	-0.09%	-0.61%	6.04%	2.40%	3.44%
Gross Profit	21.78B	21.62B	21.15B	22.50B	23.21B	26.51B
Gross Margin	79.76%	79.26%	77.99%	78.26%	78.84%	87.06%
Operating Income	11.93B	10.97B	9.33B	10.69B	11.82B	2.71B
Net Income	6.23B	4.59B	5.67B	480.00M	8.51B	-3.47B
EPS	-	-	-	-	8.15	-0.79
Dividend / Share	2.84	2.92	3.00	3.08	3.16	3.25
Dividend Growth	-	2.82%	2.74%	2.67%	2.60%	2.73%
Free Cash Flow	10.20B	6.94B	8.50B	10.13B	7.54B	1.02B
No. Analysts	-	-	-	-	-	24

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	31.0B
Avg	30.5B
Low	30.1B

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.4%
Avg	3.4%
Low	2.1%

EPS Forecast

EPS	2026	2027	2028
High	-0.63
Avg	-0.79
Low	-1.05

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-